Novo Nordisk
NVO
#102
Rank
โ‚น15.203 T
Marketcap
โ‚น3,399
Share price
-0.99%
Change (1 day)
-42.56%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.827 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.859 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.976 T6.28%
2024 โ‚น1.859 T28.01%
2023 โ‚น1.453 T57.81%
2022 โ‚น920.75 B5.24%
2021 โ‚น874.94 B12.38%
2020 โ‚น778.54 B13.11%
2019 โ‚น688.31 B-3.45%
2018 โ‚น712.90 B1.88%
2017 โ‚น699.72 B4.3%
2016 โ‚น670.85 B10.32%
2015 โ‚น608.09 B7.47%
2014 โ‚น565.84 B3.4%
2013 โ‚น547.22 B19.09%
2012 โ‚น459.52 B15.58%
2011 โ‚น397.58 B16.58%
2010 โ‚น341.05 B25.66%
2009 โ‚น271.41 B10.68%
2008 โ‚น245.23 B55.82%
2007 โ‚น157.38 B7.02%
2006 โ‚น147.05 B19.05%
2005 โ‚น123.52 B10.55%
2004 โ‚น111.73 B
2002 โ‚น76.85 B-14.39%
2001 โ‚น89.76 B-52.82%
2000 โ‚น190.24 B250%
1999 โ‚น54.35 B31.21%
1998 โ‚น41.42 B34.31%
1997 โ‚น30.84 B11.46%
1996 โ‚น27.66 B9.03%
1995 โ‚น25.37 B-3.15%
1994 โ‚น26.20 B-0.67%
1993 โ‚น26.37 B45.38%
1992 โ‚น18.14 B-13.81%
1991 โ‚น21.05 B37.12%
1990 โ‚น15.35 B-0.79%
1989 โ‚น15.47 B26.2%
1988 โ‚น12.26 B24.97%
1987 โ‚น9.81 B-0.9%
1986 โ‚น9.90 B-7.78%
1985 โ‚น10.73 B24.87%
1984 โ‚น8.59 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น961.20 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.426 T 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น726.11 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น879.71 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA